On Migrating Minds

Regarding your cover story on "Migrating Minds,"1 it is true; very often, the pre- and postdocs would buy only a one-way ticket to the United States. Why is it so? My personal opinion is that the European laws and immigration regulations imposed on universities are very restrictive, in a sense. This is not the question of money only to attract outside-EU scientists—it is a question of prospects and social stability that are offered not only to the candidate for a specific job, but also to

Written byBorislav Dimitrov
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

My personal opinion is that the European laws and immigration regulations imposed on universities are very restrictive, in a sense. This is not the question of money only to attract outside-EU scientists—it is a question of prospects and social stability that are offered not only to the candidate for a specific job, but also to his/her family.

My impression is that these restrictions are mainly related to the fact that the university bodies in Europe are requested to prove to immigration authorities first that no EU-citizen exists to compete for the advertised academic position and just, thereafter, the university bodies could hire the candidate that is not an EU-citizen. In other words, they need to prove not that the candidate from outside EU is the right one they want for the job, but that there is no better one home-raised. It is somewhat ridiculous since no suitable candidate from within ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies